BioSyent, Inc. (BIOYF)
8.73
-0.09
(-1.02%)
USD |
OTCM |
Dec 10, 14:57
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 98.32M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 10.37% |
| Valuation | |
| PE Ratio | 16.21 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 3.313 |
| Price to Book Value | 3.428 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.0355 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.0224 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 42.71% |
Profile
| BioSyent, Inc. is a specialty pharmaceutical company, which engages in the development of pharmaceutical and healthcare products. Its products include Cathejell Jelly, FeraMAX Pd Therapeutic 150, FeraMAX Pd Powder 15, Proktis-M, RepaGyn, and cTIBELLA. The company was founded on April 28, 1947 and is headquartered in Mississauga, Canada. |
| URL | http://www.biosyent.com |
| Investor Relations URL | http://www.biosyent.com/rx/investors_stock/ |
| HQ State/Province | Ontario |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Mar. 12, 2026 (est.) |
| Last Earnings Release | Nov. 20, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Nov. 28, 2025 |
Ratings
Profile
| BioSyent, Inc. is a specialty pharmaceutical company, which engages in the development of pharmaceutical and healthcare products. Its products include Cathejell Jelly, FeraMAX Pd Therapeutic 150, FeraMAX Pd Powder 15, Proktis-M, RepaGyn, and cTIBELLA. The company was founded on April 28, 1947 and is headquartered in Mississauga, Canada. |
| URL | http://www.biosyent.com |
| Investor Relations URL | http://www.biosyent.com/rx/investors_stock/ |
| HQ State/Province | Ontario |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Mar. 12, 2026 (est.) |
| Last Earnings Release | Nov. 20, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Nov. 28, 2025 |